{"id":"https://genegraph.clinicalgenome.org/r/72e730ba-0dce-4893-981e-30471ad2e6cdv1.0","type":"EvidenceStrengthAssertion","dc:description":"GABRB3 was first reported in relation to autosomal dominant developmental and epileptic encephalopathy in 2016 (Epi4K Consortium et al., 27476654). Evidence supporting this gene-disease relationship includes case-level and experimental data. Many de novo missense variants have been reported in humans, which reaches the maximum score for genetic evidence (Epi4K Consortium et al. 2016, 27476654; Zhang et al. 2015, 26544041; Le et al. 2017, 28544625; Sterbova et al. 2018, 29444535). This gene-disease association is supported by functional alteration evidence and mouse models (Janve et al. 2016, 26950270; Hernandez et al. 2017, 29162865; Moller et al. 2017, 28053010; DeLorey et al. 2008, 17983671; Ferguson et al. 2007; 17927825). A global knockout and a forebrain selective knockout mouse model were each scored for replicating seizure phenotypes, but were downgraded because the homozygous models do not replicate the heterozygous mechanism observed in humans. Of note, missense variants have been reported to segregate in three families with familial GEFS+. One affected individual of each family is likely a phenocopy, as they do not carry the reported GABRB3 variant (Moller et al. 2017, 28053010). These families were not curated as part of the GABRB3-autosomal dominant developmental epileptic encephalopathy. In summary, GABRB3 is definitively associated with autosomal dominant developmental epileptic encephalopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Epilepsy Gene Curation Expert Panel on 2/5/2019.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/72e730ba-0dce-4893-981e-30471ad2e6cd","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2019-02-05T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec3fa254-0c68-40f3-855d-8a368a3f36e3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant absent from gnomAD","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5257ded-8ff9-4d8b-a61d-c882d6acfb01","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28544625","rdfs:label":"Le Patient 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"detectionMethod":"Trio","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002069","obo:HP_0000752","obo:HP_0002384","obo:HP_0002123","obo:HP_0000717"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec3fa254-0c68-40f3-855d-8a368a3f36e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28544625","allele":{"id":"https://genegraph.clinicalgenome.org/r/27a1f836-52d9-4340-8d12-9458a7ad1b15","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000814.5(GABRB3):c.695G>A (p.Arg232Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/393256"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9f742c5d-b97d-4597-97cc-9e6e3d52d03b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Not scored because the variant is synonymous.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/170e5c67-e007-44ff-a404-0b659d97fcbe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","rdfs:label":"EG0254","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"detectionMethod":"sequenced 27 candidate epileptic encephalopathy genes","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0002373","obo:HP_0002069","obo:HP_0001256"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9f742c5d-b97d-4597-97cc-9e6e3d52d03b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","allele":{"id":"https://genegraph.clinicalgenome.org/r/22353663-de22-4a7e-b6c7-f8bf2528d1ee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021912.4(GABRB3):c.358G>A (p.Asp120Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254261"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ed6c4842-c7c2-4b4e-93e7-57ce4aabf7d2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Downgraded because only 27 genes were sequenced and maternity/paternity was not confirmed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/115c4bc0-0b58-463c-b94d-0945acc8d8e6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","rdfs:label":"EG1542","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"sequenced 27 candidate epileptic encephalopathy genes","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0010864","obo:HP_0001263","obo:HP_0200134","obo:HP_0002069"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed6c4842-c7c2-4b4e-93e7-57ce4aabf7d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","allele":{"id":"https://genegraph.clinicalgenome.org/r/2cf39e9c-6fee-4da9-90ca-c1ddf384b3cc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.26567649A>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391463214"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/469419d7-adbc-4f45-aedc-9299121da7be_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant absent from gnomAD. Variant confirmed in both affected twins, and confirmed absent in both parents. Maternity and paternity confirmed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/047eb1c4-6987-4f54-8f61-2fcd0c64d6ca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29444535","rdfs:label":"Sterbova Twins","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"detectionMethod":"97 gene panel","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"neonatal epilepsy of infancy with migrating focal seizures","phenotypes":"obo:HP_0200134","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/469419d7-adbc-4f45-aedc-9299121da7be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29444535","allele":{"id":"https://genegraph.clinicalgenome.org/r/33e3a1ae-e63f-4ce5-806e-c2594085d913","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278631.1(GABRB3):c.586A>G (p.Thr196Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/548619"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/279b2f4b-6510-42dd-a536-ffbb438d1cd1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant absent from gnomAD. Downgraded because only 27 genes were sequenced and maternity/paternity was not confirmed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/620313dd-acf4-45f9-a666-a8dfe2d51a82","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","rdfs:label":"T25111","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"detectionMethod":"Sequenced 27 candidate epileptic encephalopathy genes","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0200134","obo:HP_0002069","obo:HP_0010864"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/279b2f4b-6510-42dd-a536-ffbb438d1cd1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4fc7763-a4ef-48da-8bfe-70219a000f90","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021912.4(GABRB3):c.745C>A (p.Gln249Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254263"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/29112ed5-10c0-4f35-bb50-d0719e78ea52_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant absent from gnomAD. Different amino acid change at same position is seen in another individual with DEE from another paper (27476654). Maternity/paternity not confirmed, but variant not downgraded because of the second pathogenic variant at the same amino acid location.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df4fbb9a-5389-429d-acae-e7e50e230c0c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26544041","rdfs:label":"1538","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"detectionMethod":"NGS of 300 genes associated with epilepsy","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0010864","obo:HP_0002069","obo:HP_0007359"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/29112ed5-10c0-4f35-bb50-d0719e78ea52_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26544041","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f540430-72ed-47b7-aeb8-407204863c08","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.26561098G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391462104"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/786239cd-4f3d-4400-8048-6d6564ed4d3f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Downgraded for minimal information on the patient, and no maternity/paternity testing. Also, not confirmed that the entered variant is the correct basepair change, because it is not reported in the paper.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5fa6d189-1993-41fe-9ae5-39e21fa58b59","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26704558","rdfs:label":"EP29","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","phenotypes":["obo:HP_0001699","obo:HP_0200134"],"previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/786239cd-4f3d-4400-8048-6d6564ed4d3f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26704558","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3823b52-fea6-454d-9d28-2f0d389d9cdd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021912.4(GABRB3):c.545A>T (p.Tyr182Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254262"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/577da2cd-7c63-4b9c-a1ed-92d35c175eea_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Downgraded because only 27 genes were sequenced and maternity/paternity was not confirmed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39a1b3fa-f92b-4c3c-8c1e-a9ca0ad1f990","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","rdfs:label":"T22598","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"detectionMethod":"Sequenced 27 epileptic encephalopathy genes","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"horizontal head shaking, retained awareness","phenotypes":["obo:HP_0001263","obo:HP_0000273","obo:HP_0200134"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/577da2cd-7c63-4b9c-a1ed-92d35c175eea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3823b52-fea6-454d-9d28-2f0d389d9cdd"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fae846ee-7e28-453c-9308-57839c563ba0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD, and confirmed absent from parents. Maternity/paternity not confirmed. Variant is also seen in another proband (PMID: 26993267).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c563e7bb-8dd9-4fcf-acf2-f447864e601c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26645412","rdfs:label":"Papandreou","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"detectionMethod":"48 gene panel of early infantile epileptic encephalopathy genes, Sanger sequencing of proband and parents","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0010818","obo:HP_0002123","obo:HP_0008947","obo:HP_0010864","obo:HP_0011153","obo:HP_0011344","obo:HP_0001531"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fae846ee-7e28-453c-9308-57839c563ba0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26645412","allele":{"id":"https://genegraph.clinicalgenome.org/r/dc913d97-faf9-4601-9eec-f9eb922a17c9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.26561152G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391462328"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4a36a0b0-02ef-42b1-94de-89b44366a524_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Downgraded because only 27 genes were sequenced, and maternity/paternity was not confirmed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd1460a6-6343-4048-9051-69e29453c632","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","rdfs:label":"T25708","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":5,"detectionMethod":"sequenced 27 candidate epileptic encephalopathy genes","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"altered facial expression, stiffening of arms, eye rolling","phenotypes":["obo:HP_0010864","obo:HP_0030842"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4a36a0b0-02ef-42b1-94de-89b44366a524_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7f69cda-261f-43de-b6d5-77d1234a1cf0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021912.4(GABRB3):c.913G>A (p.Ala305Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254264"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2ab3fdee-fe62-462f-a31f-ddeda60d3d66_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Downgraded because maternity/paternity not confirmed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cf16cfd-b8cb-4899-9ed6-fa96635fbeaa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26544041","rdfs:label":"SYH","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"detectionMethod":"NGS of 300 genes associated with epilepsy","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0010864","obo:HP_0007359"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2ab3fdee-fe62-462f-a31f-ddeda60d3d66_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26544041","allele":{"id":"https://genegraph.clinicalgenome.org/r/eac695de-5f9f-4b29-962d-5de31a6c14ef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000814.5(GABRB3):c.509T>G (p.Leu170Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/449695"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdbf5e7a-e961-470b-b200-4dad8d4de77b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Not scored because this variant segregates with GEFS+ in the individual's family. This is a separate disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/565cf093-bf7d-406a-88d7-53b44babfe92","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","rdfs:label":"EG0258","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":8,"detectionMethod":"Sequenced 27 candidate epileptic encephalopathy genes","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0002373","obo:HP_0001256","obo:HP_0002069"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fdbf5e7a-e961-470b-b200-4dad8d4de77b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","allele":{"id":"https://genegraph.clinicalgenome.org/r/ff1a36aa-c0ff-4e76-845c-30dfcdc7cf77","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.26583406G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391458132"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e16dbb1e-c4ac-42cb-b1c5-72c0695bcb45_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Inheritance is unknown so not scored.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf42bbb0-946b-41a5-b9ec-a53e3f0f5958","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","rdfs:label":"T23950","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":1,"detectionMethod":"sequenced 27 candidate epileptic encephalopathy genes","phenotypes":["obo:HP_0002123","obo:HP_0200134","obo:HP_0002187"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e16dbb1e-c4ac-42cb-b1c5-72c0695bcb45_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476654","allele":{"id":"https://genegraph.clinicalgenome.org/r/e387e70b-a997-4fc2-85cd-f1f58adb5303","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.26561134A>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391462269"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/823c8679-583e-452e-b294-7bd8494fb172","type":"EvidenceLine","dc:description":"Downgraded because mouse model has seizures but does not have a consistent genotype with affected humans.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de670c60-e05e-4a85-ba01-67c6ecad12f5","type":"Finding","dc:description":"Forebrain selective knockout mice have occasional absence-like and convulsive seizures. This study also tested Pan-neuronal knockout mice, which do not have observable seizures and is therefore not scored for this curation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17927825","rdfs:label":"Forebrain selective KO","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/827f2298-40c3-4724-bf24-4c4c259ac3fa","type":"EvidenceLine","dc:description":"See also, Homanics 1997 (PMID 9108119) for phenotyping. Downgraded because this model is homozygous, which is not a genotypic match to the dominant disease mechanism.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/753b45ff-c3c8-46cd-89da-e09ac7b05732","type":"Finding","dc:description":"Result of mouse knockout is a varying age range of mice, which they age-matched with control mice. gabrb3-/- mice were hyperactive. In a nesting test, which represents a homecage-activity that is linked to social behavior, gabrb3-/- made flat nests of unshredded nesting material while control mice build well-assembled walls or cocoon-like nests from fully shredded nesting material. The KO mice only slept in the nest 50% of the time, while control mice spelt in their nests 100% of the time. Control mice spent longer investigating a novel object than KO mice (exploratory behavior). KO mice showed circling behavior. Semi-quantitative measurements of sagittal surface area of cerebellar vermal lobules shows significant decreases in the surface area of vermal lobules II, III, IV-V and VI-VII in KO mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17983671","rdfs:label":"DeLorey Knockout Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a9327dac-6f76-4881-8a23-ef2b210f92e7_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94cca72c-1ce6-4ad5-b71e-4aab9db79dab","type":"EvidenceLine","dc:description":"Upgraded because the p.D120N, p.E180G and p.Y302C variants were shown to have a pathogenic effect.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/569ddd29-b943-4a3c-aec7-f3dd7ee123dd","type":"FunctionalAlteration","dc:description":"GABRB3 variants p.D120N, p.E180G, and p.Y302C are located at β+ subunit interfaces and they reduced whole cell currents by decreasing single channel open probability without loss of surface receptors. p.E180G variant also produced spontaneous channel openings","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26950270","rdfs:label":"Janve Functional Alteration"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/64050fb1-074d-4477-a324-b3c8960b010b","type":"EvidenceLine","dc:description":"Upgraded because p.Y184H, p.L256Q, and p.Y302C were scored in cases, and this evidence is proof of variant pathogenicity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d5708b6-bc94-4ee8-ae6e-9303588b27ee","type":"FunctionalAlteration","dc:description":"strongly and significantly reduced current amplitudes found in p.V37G, p.Y184H, p. L256Q, p.R111X, and p.Y302C. Also investigated change in GABA sensitivity, and found p.Y302C and p.Y184H have significantly reduced GABA sensitivity","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28053010","rdfs:label":"Moller Functional Study"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c5d67ff2-347b-458c-a36e-5cf79fed4d40","type":"EvidenceLine","dc:description":"Upgraded because p.L170R, p.A305V, and T288N were shown to have a pathogenic effect.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb08043d-cc90-49b2-ae58-224e74dbb83e","type":"FunctionalAlteration","dc:description":"Peak GABA-gated current amplitudes were significantly reduced in cells expressing mutant β3 subunits with p.L170R, p.A305V, and p.T288N variants to ~80%, 50% and 60% of those expressing wildtype β3 subunits.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29162865","rdfs:label":"Hernandez Functional Evidence"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":425,"specifiedBy":"GeneValidityCriteria6","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Jy4wfuZ9OAw","type":"GeneValidityProposition","disease":"obo:MONDO_0100062","gene":"hgnc:4083","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a9327dac-6f76-4881-8a23-ef2b210f92e7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}